Have a feature idea you'd love to see implemented?
Let us know!
BJDX Bluejay Diagnostics Inc
Price (delayed)
$3.52
Market cap
$1.89M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1,372
Enterprise value
-$3.62M
Highlights
BJDX's EPS has soared by 65% YoY and by 38% QoQ
Bluejay Diagnostics's debt has decreased by 43% from the previous quarter and by 38% YoY
BJDX's equity is up by 37% year-on-year but it is down by 17% since the previous quarter
Key stats
What are the main financial stats of BJDX
Market
Valuations
Earnings
Shares outstanding
537,679
Market cap
$1.89M
Enterprise value
-$3.62M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.06
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$7.77M
EBITDA
-$7.55M
Free cash flow
-$9.25M
Per share
Balance sheet
Liquidity
EPS
-$1,372
Free cash flow per share
-$48.41
Book value per share
$57.3
Revenue per share
$0
TBVPS
$43.71
Total assets
$8.35M
Total liabilities
$1.19M
Debt
$241,652
Equity
$7.16M
Working capital
$5.52M
Debt to equity
0.03
Current ratio
6.26
Quick ratio
5.49
Net debt/EBITDA
0.73
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-117.8%
Return on equity
-155.7%
Return on invested capital
-574.9%
Return on capital employed
-106.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BJDX stock price
How has the Bluejay Diagnostics stock price performed over time
Intraday
0.57%
1 week
6.34%
1 month
-36.12%
1 year
-99.72%
YTD
-99.28%
QTD
-44.57%
Financial performance
How have Bluejay Diagnostics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.07M
Net income
-$8.59M
Gross margin
N/A
Net margin
N/A
BJDX's operating income is up by 22% year-on-year and by 11% since the previous quarter
BJDX's net income is up by 14% year-on-year and by 9% since the previous quarter
Growth
What is Bluejay Diagnostics's growth rate over time
Valuation
What is Bluejay Diagnostics stock price valuation
P/E
N/A
P/B
0.06
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
BJDX's EPS has soared by 65% YoY and by 38% QoQ
BJDX's P/B is 80% below its last 4 quarters average of 0.3
BJDX's equity is up by 37% year-on-year but it is down by 17% since the previous quarter
Efficiency
How efficient is Bluejay Diagnostics business performance
Bluejay Diagnostics's return on invested capital has increased by 28% QoQ but it has decreased by 16% YoY
Bluejay Diagnostics's return on equity has decreased by 25% YoY but it has increased by 17% QoQ
The ROA has contracted by 21% YoY but it has grown by 9% from the previous quarter
Dividends
What is BJDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BJDX.
Financial health
How did Bluejay Diagnostics financials performed over time
Bluejay Diagnostics's current ratio has soared by 169% YoY and by 43% from the previous quarter
Bluejay Diagnostics's total liabilities has shrunk by 61% YoY and by 46% QoQ
Bluejay Diagnostics's debt is 97% less than its equity
The company's debt to equity has shrunk by 57% YoY and by 40% QoQ
Bluejay Diagnostics's debt has decreased by 43% from the previous quarter and by 38% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.